Related by context. Frequent words. (Click for all words.) 80 FDA Accepts 77 Generic Version 74 Pivotal Phase III 72 FDA Clears 72 Drug Candidate 72 Patient Enrollment 72 Completes Enrollment 71 Clinical Trial Results 71 Positive Opinion 70 Phase III Clinical Trial 70 FDA Clearance 70 Phase III Trial 68 Presents Positive 68 Fast Track Designation 68 FDA Approval 68 Pivotal Trial 68 Receives FDA Clearance 68 Preclinical Data 68 Cholesterol Drug 68 Metastatic Colorectal Cancer 68 Pivotal Phase 68 Initiate Phase 67 Full Prescribing Information 67 Patent Covering 67 Extended Release 67 FDA Approves 67 Complete Response 66 Patent Lawsuit 66 Recombinant Human 66 sBLA 66 Low Dose 66 Kuvan R 65 supplemental Biologics License Application 65 Ixempra 65 Orphan Drug Status 65 Marketing Authorization Application 65 Well Tolerated 65 submitted Biologics License 65 Transcept Pharmaceuticals 65 refractory chronic lymphocytic 65 k Clearance 64 Blood Thinner 64 Initiates Phase 64 Patent Infringement Lawsuit 64 Panzem R 64 Significantly Reduces 64 Combination Therapy 63 RNAi Therapeutics 63 Irinotecan 63 FDA Orphan Drug 63 Advanced Prostate Cancer 63 Application MAA 63 Announces Initiation 63 II Clinical Trial 63 Reduces Risk 63 Aliskiren 63 Application BLA 63 Small Molecule 63 FDA Warns 63 Smallpox Vaccine 63 Vandetanib 62 Patients Treated 62 Monoclonal Antibody 62 Cervical Cancer Vaccine 62 Receives Patent 62 VALSTAR 62 Extended Release Tablets 62 Marketing Authorisation 62 Study Demonstrates 62 Diet Pill 62 Drug Application 62 Anti Inflammatory 61 Citizen Petition 61 Receives Positive 61 Patent Issued 61 Pirfenidone 61 Cethromycin 61 Boceprevir 61 Issues Guidance 61 Hycamtin 61 REVLIMID R 61 Orphan Drug status 61 R sorafenib tablets 61 BioDelivery Sciences 61 Bevacizumab 61 Belinostat 61 Files Patent 61 application sNDA 60 Achieves Milestone 60 Oral Solution 60 Biologics License Application 60 Shows Promise 60 Ranexa R 60 Boxed Warning 60 KRN# 60 Ofatumumab 60 Entereg R 60 Tesetaxel 60 Cancer Treatments 60 Investigational Device Exemption 60 Exclusive License